Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans

Annals of the Rheumatic Diseases

Volumn 67, Issue 9, 2008, Pages 1310-1316

  Singh, J A ^a,b   Strand, V ^c  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; GOUT; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SOCIOECONOMICS; VETERAN;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF LIFE; UNITED STATES; VETERANS;

EID: 50349101970     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.081604     Document Type: Article

References (48)

1. Yu W, Ravelo A, Wagner T, Phibbs C, Bhandari A, Chen S, et al. Prevalence and costs of chronic conditions in the VA health care system. Med Care 2003;60:146-67S.
2. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20.
3. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002;41:793- 800.
4. Saraux A, Guedes C, Allain J, Devauchelle V, Valls I, Lamour A, et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J Rheumatol 1999;26:2622-7.
5. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
6. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16:427-41.
7. Krishnan E, Griffith C, Kwoh K. Rurden of illness from gout in ambulatory care in the United States. Arthritis Rheum 2005;52(Suppl):S656.
8. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 2005;44:1038-42.
9. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-72.
10. Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum 2007;57:822-9.
11. Brown GM, Dare CM, Smith PR, Meyers QL. Important problems identified by patients with chronic arthritis. S Afr Med J 1987;72:126-8.
12. Alvarez-Nemegyei J, Cen-Piste JC, Medina-Escobedo M, Villanueva-Jorge S. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout. J Rheumatol 2005;32:1923-7.
13. Kleinman N, Patel P, Brook R, Melkonian A, Smeeding J, Joseph-Ridge N. Lost days and productivity impact of gout [abstract]. Arthritis Rheum 2005;52(Suppl):S657.
14. Yu T. The efficacy of colchicine prophylaxis in articular gout - a reappraisal after 20 years. Semin Arthritis Rheum 1982;12:256-64
15. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects. Ann Intern Med 1961;55:179-92.
16. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 2007;46:1441-4.
17. Emmerson BT. The management of gout. N Engl J Med 1996;334:445-51.
18. Rott KT, Agudelo CA. Gout. JAMA 2003;289:2857-60.
19. Ferraz MB, O'Brien B. A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis. J Rheumatol 1995;22:908-14.
20. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26.
21. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96.
22. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-61.
23. Perlin JB, Kolodner RM, Roswell RH. The Veterans Health Administration: quality, value, accountability, and information as transforming strategies for patient-centered care. Am J Manag Care 2004;10(Pt 2):828-36.
24. Cowper DC, Hynes DM, Kubal JD, Murphy PA. Using administrative databases for outcomes research: select examples from VA Health Services Research and Development. J Med Syst 1999;23:249-59.
25. Kashner TM. Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care 1998;36:1324-36.
26. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standard measure of biological and psychological function. JAMA 1963;185:914-9.
27. Singh JA, Borowsky SJ, Nugent S, Murdoch M, Zhao Y, Nelson DB, et al. Health-related quality of life, functional impairment, and healthcare utilization by veterans: veterans' quality of life study. J Am Geriatr Soc 2005;53:108-13.
28. Singh JA, Nelson DB, Fink HA, Nichol KL. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the Veterans Arthritis Quality of Life study. Semin Arthritis Rheum 2005;34:755-65.
29. Kosinski M, Keller SD, Ware JE Jr, Hatoum HT, Kong SX. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999;37(Suppl):MS23-39.
30. Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998;51:1077-86.
31. Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcon GS, et al. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol 1997;24:1910-5.
32. Kantz ME, Harris WJ, Levitsky K, Ware JE Jr, Davies AR. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care 1992;30(Suppl):MS240-52.
33. Ren XS, Kazis L, Lee A, Miller DR, Clark JA, Skinner K, et al. Comparing generic and disease-specific measures of physical and role functioning: results from the Veterans Health Study. Med Care 1998;36:155-66.
34. Ware JE, Kosinski M, Dewey J. How to score version two of the SF-36 Health Survey. 3rd ed. Lincoln, Rhode Island, USA: QualityMetric Inc. 2000.
35. Kazis L, Skinner K, Rogers W, Lee A, Ren X, Miller D, et al. Health status in VA patients: results from the Veterans Health Study. Am J Med Qual 1999;14:28-38.
36. Kazis LE, Miller DR, Clark J, Skinner K, Lee A, Rogers W, et al. Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch Intern Med 1998;158:626-32.
37. Szeto HC, Coleman RK, Gholami P, Hoffman BB, Goldstein MK. Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. Am J Manag Care 2002;8:37-43.
38. Petersen LA, Wright S, Normand SL, Daley J. Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 1999;14:555-8.
39. Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum 2007;57:822-9.
40. Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832-40.
41. Strand V. Longer term benefits of treating rheumatoid arthritis: assessment of radiographic damage and physical function in clinical trials. Clin Exp Rheumatol 2004;22(Suppl 35):S57-64.
42. Strand V, Crawford B. Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies. Expert Review of Pharmacoeconomics and Outcomes Research 2005;5:317-26.
43. Strand V, Kelman A. Outcome measures in osteoarthritis: randomized controlled trials. Curr Rheumatol Rep 2004;6:20-30.
44. Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006;33:104-9.
45. Osterhaus JT, Patel P, Williams AP, Bakst A, Joseph-Ridge N. Patient reported outcomes assoicated with gout: baseline results from two clinical trials [abstract]. Arthritis Rheum 2005;52(Suppl):S 401-2.
46. Kramer HM, Curhan G, The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42.
47. Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, et al. Validity of gout diagnoses in administrative data. Arthritis Rheum 2007;57:103-8.
48. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ. Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care 1992;30:377-91.